CORRECTION: Travere Therapeutics Q3 EPS $(0.13) Beats $(0.54) Estimate, Sales $68.22M Beat $60.93M Estimate
Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.54) by 75.93 percent. This is a 18.18 percent decrease over losses of $(0.11) per share